| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 3,431,000 | 3,643,000 | 3,674,000 | 3,578,000 | | Cost of Revenue | 1,440,000 | 5,693,000 | 1,633,000 | 1,584,000 | | | Gross Profit | 1,991,000 | (2,050,000) | 2,041,000 | 1,994,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,059,000 | (3,010,000) | 983,000 | 991,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 419,000 | 410,000 | 419,000 | 419,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 513,000 | 550,000 | 639,000 | 584,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 30,000 | 51,000 | 6,000 | 34,000 | | Earnings Before Interest And Taxes | 543,000 | 601,000 | 645,000 | 618,000 | | Interest Expense | 173,000 | 148,000 | 178,000 | 185,000 | | Income Before Tax | 370,000 | 453,000 | 467,000 | 433,000 | | Income Tax Expense | 131,000 | 75,000 | 163,000 | 140,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 239,000 | 378,000 | 304,000 | 293,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 239,000 | 378,000 | 304,000 | 293,000 | | Preferred Stock And Other Adjustments | (3,000) | (14,000) |
-
|
-
| | | Net Income Applicable To Common Shares | $236,000 | $364,000 | $304,000 | $293,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
